Leading African pharmaceutical Cooper Pharma broke ground for their $USD 6 million pharmaceutical plant in Rwanda, The factory whose completion is set for 2019, will produce beta-lactam antibiotics and non-beta lactam antibiotics according to the market’s demand. To better understand how this will help Rwanda reduce the import bill on drugs, CNBC Africa’s Michael Mugisha filed this report.
Cooper Pharma launches construction of $6mn pharmaceutical plant in Rwanda
PUBLISHED: Wed, 20 Dec 2017 10:17:29 GMT